These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26184060)

  • 1. Phenylketonuria, an unusual diagnosis of mental retardation in an adult patient.
    Papassin J; Pierunek J; Corne C; Besson G
    Rev Neurol (Paris); 2015 Oct; 171(10):739-40. PubMed ID: 26184060
    [No Abstract]   [Full Text] [Related]  

  • 2. Musty odour, mental retardation, and spastic paraplegia revealing phenylketonuria in adulthood.
    Jousserand G; Antoine JC; Camdessanché JP
    J Neurol; 2010 Feb; 257(2):302-4. PubMed ID: 19862469
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenylketonuria and anorexia nervosa.
    Clarke DJ; Yapa P
    J Ment Defic Res; 1991 Apr; 35 ( Pt 2)():165-70. PubMed ID: 1906546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One too many: intellectual disability secondary to undiagnosed phenylketonuria.
    Hui J; Chong SC; Law LK; Lee LK; Chang S; Yau P; Yuen YP
    Hong Kong Med J; 2016 Oct; 22(5):506-8. PubMed ID: 27738300
    [No Abstract]   [Full Text] [Related]  

  • 5. Mental retardation in a family with phenylketonuria and mild hyperphenylalaninemia.
    Cohen BE; Szeinberg A; Berman W; Aviad Y; Crispin M; Hirshorn N; Goland R
    Pediatrics; 1969 Nov; 44(5):655-60. PubMed ID: 5374976
    [No Abstract]   [Full Text] [Related]  

  • 6. Phenylketonuria in Kuwait and Arab countries.
    Teebi AS; Al-Awadi SA; Farag TI; Naguib KK; el-Khalifa MY
    Eur J Pediatr; 1987 Jan; 146(1):59-60. PubMed ID: 3582406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylketonuria and scleroderma.
    Lasser AE; Schultz BC; Beaff D; Bielinski S; Kirschenbaum B
    Arch Dermatol; 1978 Aug; 114(8):1215-7. PubMed ID: 677922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete reversal of moderate/severe brain MRI abnormalities in a patient with classical phenylketonuria.
    Walter JH; White F; Wraith JE; Jenkins JP; Wilson BP
    J Inherit Metab Dis; 1997 Jul; 20(3):367-9. PubMed ID: 9266357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Brain atrophy and disorders of the amino acid metabolism].
    Bickel H
    Monatsschr Kinderheilkd (1902); 1967 Apr; 115(4):254-8. PubMed ID: 5592531
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenylketonuria is still a major cause of mental retardation in Tunisia despite the possibility of treatment.
    Khemir S; El Asmi M; Sanhaji H; Feki M; Jemaa R; Tebib N; Dhondt JL; Ben Dridi MF; Mebazaa A; Kaabachi N
    Clin Neurol Neurosurg; 2011 Nov; 113(9):727-30. PubMed ID: 21862209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylalanine-restricted diets in the treatment of phenylketonuria.
    BLAINEY JD; GULLIFORD R
    Arch Dis Child; 1956 Dec; 31(160):452-66. PubMed ID: 13395572
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenylketonuria: metabolic alterations induced by phenylalanine and phenylpyruvate.
    Patel MS; Arinze IJ
    Am J Clin Nutr; 1975 Feb; 28(2):183-8. PubMed ID: 234671
    [No Abstract]   [Full Text] [Related]  

  • 13. Malnutrition with early treatment of phenylketonuria.
    Hanley WB; Linsao L; Davidson W; Moes CA
    Pediatr Res; 1970 Jul; 4(4):318-27. PubMed ID: 5447890
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyruvate metabolism by homogenates of human brain: effects of phenylpyruvate and implications for the etiology of the mental retardation in phenylketonuria.
    Patel MS; Grover WD; Auerbach VH
    J Neurochem; 1973 Feb; 20(2):289-96. PubMed ID: 4698280
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurological deterioration in young adults with phenylketonuria.
    Thompson AJ; Smith I; Brenton D; Youl BD; Rylance G; Davidson DC; Kendall B; Lees AJ
    Lancet; 1990 Sep; 336(8715):602-5. PubMed ID: 1975386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood phenylalanine levels in mentally retarded African children: a study of 138 patients from Ibadan, Nigeria.
    Familusi JB; Bolodeoku JO
    Trop Geogr Med; 1976 Jun; 28(2):96-100. PubMed ID: 973249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Man made disease: clinical manifestations of low phenylalanine levels in an inadequately treated phenylketonuria patient and mouse study.
    Pode-Shakked B; Shemer-Meiri L; Harmelin A; Stettner N; Brenner O; Abraham S; Schwartz G; Anikster Y
    Mol Genet Metab; 2013; 110 Suppl():S66-70. PubMed ID: 24206931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrecognized maternal biochemical disease: an uncommon cause of mental retardation in children.
    Perry TL; Bunting R; Tischler B; Hansen S; Diamond S; Weppler VC
    J Ment Defic Res; 1970 Mar; 14(1):44-8. PubMed ID: 5517963
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical phenylketonuria in a seven-year-old profoundly retarded girl: development of phenylalanine tolerance, in spite of apparently continued failure to convert phenylalanine to tyrosine.
    Cohn GH; Ouellette EM; Moser HW; Efron ML
    Neurology; 1968 Mar; 18(3):310-1. PubMed ID: 5690427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.